• Home
  • Pharmacy Medical Policy Updates

Pharmacy Medical Policy Updates

The following Pharmacy Medical Policy programs have been updated Oct. 1, 2021:

Effective Nov. 1, 2021:

  • Healthcare Administered Multiple Sclerosis (formerly IV Multiple Sclerosis)
  • Multiple Sclerosis
  • Hepatitis C Direct Acting Antivirals
  • Injectable and Healthcare Administered Oncology
  • Rituximab
  • Xermelo
  • Peg-interferon
  • GLP-1 Agonists
  • Insulin Combination
  • Lupus
  • Thyroid Eye Disease
  • IL-4 Inhibitors

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization

If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.

Institutional Providers
Professional Providers